← Back to Search

Physical Activity Together for PwMS and their CGs (PAT-MS) for Multiple Sclerosis (PAT-MS Trial)

N/A

Waitlist Available

Led By Mark Freedman, MD

Research Sponsored by University of Ottawa

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up recorded from study initiation to completion, approximately 2 years

Awards & highlights

PAT-MS Trial Summary

This trial will test whether the dyadic approach to PA is an effective way to manage MS for both patients and caregivers.

Eligible Conditions

Multiple Sclerosis

PAT-MS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ recorded from study initiation to completion, approximately 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~recorded from study initiation to completion, approximately 2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and recorded from study initiation to completion, approximately 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Self-Reported Physical Activity - Primary Efficacy Outcome

Feasibility: Data collection at T1

Feasibility: Data collection at T2

+7 more

Secondary outcome measures

Change in Accelerometer-measured Physical Activity - minutes of PA

Change in Accelerometer-measured Physical Activity - steps/day

Change in Agility

+10 more

Other outcome measures

Experiential Aspects of Participation

Satisfaction Survey

Semi-structured Qualitative Interview

PAT-MS Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Immediate InterventionExperimental Treatment1 Intervention

PwMS-CG dyads will receive six group telerehabilitation sessions (~60 min each) every other week for a period of 12 weeks. This will be interspersed with brief one-on-one support telephone calls in the weeks that group sessions do not occur. All participants will be taught techniques for monitoring PA behaviour, setting personalized goals to increase PA and reduce sedentary time, and strategies for overcoming challenges to PA participation. Make-up sessions will be offered to those who miss group sessions. The one-on-one support telephone calls will serve to reinforce the information provided during the group sessions, monitor safety and troubleshoot any issues with intervention content.

Group II: Delayed ControlActive Control1 Intervention

The delayed control group will not receive the intervention during the study period. Participants assigned to the control group will be offered the intervention once the study is completed.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Physical Activity Together for PwMS and their CGs (PAT-MS)

2020

N/A

~30

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Consortium of Multiple Sclerosis CentersOTHER

8 Previous Clinical Trials

50,137 Total Patients Enrolled

8 Trials studying Multiple Sclerosis

50,137 Patients Enrolled for Multiple Sclerosis

Queen's UniversityOTHER

365 Previous Clinical Trials

120,395 Total Patients Enrolled

7 Trials studying Multiple Sclerosis

571 Patients Enrolled for Multiple Sclerosis

University of OttawaLead Sponsor

205 Previous Clinical Trials

266,069 Total Patients Enrolled

5 Trials studying Multiple Sclerosis

310 Patients Enrolled for Multiple Sclerosis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the chief aims of this experiment?

"The primary endpoint of this trial, to be assessed at 12 weeks, is the participant compliance rate. There are also secondary objectives which involve evaluating changes in physical functional limitations and disability (using the Late-Life Function and Disability Instrument), perceptions of social support (with the Interpersonal Support Evaluation List-12) and walking speed (via a timed 25-foot walk test)."

Answered by AI

Is it still possible to join this experiment?

"As indicated by the data hosted on clinicaltrials.gov, this medical trial is not presently recruiting patients and has not been updated since October 26th 2022. However, there are 553 other studies in need of participants at this time."

Answered by AI

Recent research and studies

JMIR Research ProtocolsJournal

Physical Activity Together for People with Multiple Sclerosis and Their Care Partners: Protocol for a Feasibility Randomized Controlled Trial of a Dyadic Intervention

Fakolade, Afolasade, Julie Cameron, Odessa McKenna, Marcia L Finlayson, Mark S Freedman, Amy E Latimer-Cheung, and Lara A Pilutti. 2021. “Physical Activity Together for People with Multiple Sclerosis and Their Care Partners: Protocol for a Feasibility Randomized Controlled Trial of a Dyadic Intervention”. JMIR Research Protocols. JMIR Publications Inc.. doi:10.2196/18410.

Health ExpectationsJournal

Understanding Leisure-time Physical Activity: Voices of People with MS Who Have Moderate-to-severe Disability and Their Family Caregivers

Fakolade, Afolasade, Julie Lamarre, Amy Latimer-Cheung, Trisha Parsons, Sarah A. Morrow, and Marcia Finlayson. 2017. “Understanding Leisure-time Physical Activity: Voices of People with MS Who Have Moderate-to-severe Disability and Their Family Caregivers”. Health Expectations. Wiley. doi:10.1111/hex.12600.

Disability and RehabilitationJournal

A Concerns Report Survey of Physical Activity Support Needs of People with Moderate-to-severe MS Disability and Family Caregivers

Fakolade, Afolasade, Amy Latimer-Cheung, Trisha Parsons, and Marcia Finlayson. 2018. “A Concerns Report Survey of Physical Activity Support Needs of People with Moderate-to-severe MS Disability and Family Caregivers”. Disability and Rehabilitation. Informa UK Limited. doi:10.1080/09638288.2018.1479781.

Physiotherapy CanadaJournal